May 30, 2022

Biotalys’ Evoca wins best biofungicide product award

Biotalys’ first biocontro, Evoca, won a 2022 World BioProtection Award in the Best Biofungicide Product category. The award was granted at the World BioProtection Summit taking place in Birmingham, UK, based on the innovative character, scientific value and market potential of the product.

Evoca is the first protein-based biofungicide developed on Biotalys’ AGROBODY Foundry platform. It helps control fungal diseases such as Botrytis and powdery mildew in fruits and vegetables. Once approved by regulatory authorities, Evoca will provide growers with a new rotation partner in integrated pest management (IPM) programs, reducing the dependency on chemical pesticides while protecting yields.

“We are honored to receive this global award for Evoca, the first biocontrol product developed on our unique technology platform,” said Patrice Sellès, CEO of Biotalys. “Demonstrating the strength of our technology and approach, this award recognizes the hard work of our colleagues and the scientific excellence of our teams to develop a new and effective tool for growers to protect their crops from fungal diseases.”

Biotalys recently published the key findings of its latest trials with Evoca, showing that the product consistently outperformed a leading chemical fungicide when applied at the flowering stage in a Botrytis control program in grapes. Validating the strength and efficacy of the product, the company’s global field trial program with Evoca now encompasses more than 600 independent and company-driven field and greenhouse trials across multiple seasons, regions, climates, soil types, production types, pathogen pressure and crops.

Earlier in May 2022, Evoca’s active ingredient received an entirely new resistance class by the FRAC – the Fungicide Resistance Action Committee. The new classification granted by this highly reputed international panel of renowned technical experts demonstrates to growers that the product will be a new tool that complements existing biological and conventional crop protection solutions to fight the fungal diseases Botrytis and powdery mildew. Evoca is on track to obtain approval by the U.S. Environmental Protection Agency (EPA) later this year, while EU regulatory approval is expected by the end of 2024. This will pave the way for Biotalys’ pipeline of product candidates, which includes biofungicides, biobactericides and bio-insecticides.

The World BioProtection Awards are granted by the World BioProtection Forum, a non-profit organization that encourages collaboration between the biocontrol industry and academia in the AgriTech sector. The award ceremony this year took place in Birmingham, UK, where sector leaders and academics shed their light on the importance of biological crop protection. The ceremony was attended by Frédéric Grimault, head of business development and marketing EMEA & APAC for Biotalys, who received the award at the event on behalf of the company. The award was jointly granted to both Evoca and another biofungicide. More information can be found at https://www.worldbioprotectionforum.com/awbsa2022.